Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.

Dahal K, Hendrani A, Sharma SP, Singireddy S, Mina G, Reddy P, Dominic P, Modi K

Open source

DOI
10.1001/jamainternmed.2018.0850
Published
2018 Jul 1
Container
JAMA internal medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamainternmed.2018.0850,
  title = {Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.},
  author = {Dahal K and Hendrani A and Sharma SP and Singireddy S and Mina G and Reddy P and Dominic P and Modi K},
  year = {2018},
  journal = {JAMA internal medicine},
  doi = {10.1001/jamainternmed.2018.0850},
  url = {https://doi.org/10.1001/jamainternmed.2018.0850}
}

RIS

TY  - JOUR
TI  - Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.
AU  - Dahal K
AU  - Hendrani A
AU  - Sharma SP
AU  - Singireddy S
AU  - Mina G
AU  - Reddy P
AU  - Dominic P
AU  - Modi K
PY  - 2018
JO  - JAMA internal medicine
DO  - 10.1001/jamainternmed.2018.0850
UR  - https://doi.org/10.1001/jamainternmed.2018.0850
ER  - 

APA

K, D., A, H., SP, S., S, S., G, M., P, R., P, D., & K, M. (2018). Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2018.0850

Source records